Wettstein DJ. The impact of value-based pricing policies for new medicines on negotiation behaviour and societal outcomes: implications from three economic experiments. Cumulative thesis submitted for the degree of Ph.D. in Health Sciences at the Department of Health Sciences and Medicine, University of Lucerne. (2021 forthcoming).
Wettstein DJ, Boes S. How value-based policy interventions influence price negotiations for new medicines: An experimental approach and initial evidence. Health Policy 126(2), 112-121 (2021). https://doi.org/10.1016/j.healthpol.2021.12.007
Wettstein DJ, Boes S. The Impact of Reimbursement Negotiations on Cost and Availability of New Pharmaceuticals: Evidence from an Online Experiment. Health Economics Review. 2020;10(1):13. https://doi.org/10.1186/s13561-020-00267-y
Wettstein DJ, Boes S: Assessing social preferences in reimbursement negotiations for new Pharmaceuticals in Oncology: an experimental design to analyse willingness to pay and willingness to accept. BMC Health Serv Res 2021, 21(1):234. https://doi.org/10.1186/s12913-021-06231-8
Wettstein DJ, Boes S. Effectiveness of National Pricing Policies for Patent-Protected Pharmaceuticals in the OECD: A Systematic Literature Review. Appl Health Econ Health Policy. (accepted version) 2018. Wettstein_Boes_2018
This is a post-peer-review, pre-copyedit version of an article published in Applied Health Economics and Health Policy. The final authenticated version is available online at: https://doi.org/10.1007/s40258-018-0437-z